期刊文献+

Toll样受体与肿瘤免疫 被引量:5

Toll-like receptors and tumor immunology
下载PDF
导出
摘要 Toll样受体 (TLR)是参与非特异性免疫的一类重要分子 ,也是连接非特异性免疫和特异性免疫的桥梁。新近研究发现 ,TLR能结合机体自身产生的一些内源性分子 (即内源性配体 )。免疫佐剂可增强抗肿瘤免疫 ,其分子和细胞机制得到进一步阐明 ,TLR也在其中扮演重要角色。由于肿瘤在发生发展过程中可以产生一些能被TLR识别的内源性配体 ,所以TLR在肿瘤免疫监视中可能发挥了一定作用。
作者 陈凌 廖晓龙
出处 《国外医学(肿瘤学分册)》 2004年第6期403-406,共4页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献29

  • 1Schjetne KW, Thompson KM, Nilsen N, et al. Cutting Edge:Link between innate and adaptive immunity: toll-like receptor 2 internalizes antigen for presentation to CD4 + T cells and could be an efficient vaccine target. J Immunol, 2003, 171 (1): 32-36.
  • 2Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol, 2003, 21: 335-376.
  • 3PatersonHM, MurphyTJ, PurcellEJ, et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol, 2003, 171(3): 1473-1483.
  • 4Smyth MJ, Godfrey DI, Trapani JA. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol, 2001, 2 (4):293-299.
  • 5Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer, 2003, 3(5): 362-374.
  • 6Khong HT, Restifo NP. Natural selection of tumor variants in the generation of ""tumor escape"" phenotypes. Nat Immunol, 2002, 3(5): 999-1005.
  • 7Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol, 2002, 3(12): 1129-1134.
  • 8Bendelac A, Medzhitov R. Adjuvants of immunity:harnessing innate immunity to promote adaptive immunity. J Exp Med, 2002,195(5): F19-F23.
  • 9Lawton JA, Ghosh P. Novel therapeutic strategies based on tolllike receptor signaling. Curr Opin Chem Biol, 2003, 7(4): 446-451.
  • 10Feng H, Zheng Y, Whitesell L, et al. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood, 2001, 97(11): 3505-3512.

同被引文献79

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部